Nash

  • Nash posted an update 7 months, 1 week ago

    The original article [1] contained an error whereby the captions to Fig. 3 and Fig. 8 were mistakenly interchanged.BACKGROUND Patients’ pre-operative health and physical function is known to influence their post-operative outcomes. In patients with knee osteoarthritis, pharmacological and non-pharmacological options are often not optimised prior…[Read more]

  • Nash posted an update 7 months, 1 week ago

    Communicated by Ramaswamy H. Sarma.The function of acetaldehyde dehydrogenase 1 (ALDH1) has been gradually elucidated in several diseases, especially in various cancers. However, the role of ALDH1 in skin-related diseases has been mostly unknown. Previously, we found that ALDH1 is involved in the pathogenesis of atopic dermatitis (AD). In this…[Read more]

  • Nash posted an update 7 months, 1 week ago

    Lyme disease is a multisystem infection caused by Borrelia burgdorferi that mainly affects the joints, the heart, and the nervous system. Neurological complications usually manifest in untreated patients and present as meningitis, cranial neuropathies, and radiculoneuritis. The authors present the case of a 48-year-old male who developed loss of…[Read more]

  • Nash posted an update 7 months, 1 week ago

    The neonatal Fc receptor (FcRn) transports maternal immunoglobulin G (IgG) to the foetus or newborn and protects the IgG from degradation. FcRn is expressed in several porcine tissues and cell types and its expression levels are regulated by immune and inflammatory events. IPEC-J2 cells are porcine intestinal columnar epithelial cells that were…[Read more]

  • Nash posted an update 7 months, 1 week ago

    BACKGROUND The oblique lumbar interbody fusion (OLIF) procedure may reduce many of the risks and limitations associated with lateral lumbar interbody fusion (LLIF). However, little is known about the biomechanical performance of various fixation constructs after OLIF.This study aimed to explore the stability of various fixation options for OLIF by…[Read more]

  • Nash posted an update 7 months, 2 weeks ago

    RESULTS After matching patients who had received vedolizumab with those who had received adalimumab, the rate of persistence after 3 therapy years was 30.3% for vedolizumab and 27.9% for adalimumab (log-rank p = 0.005). The corresponding figures were 27.8 and 20.8% in the vedolizumab-golimumab matched-pair analysis (log-rank p less then 0.001) and…[Read more]

  • Nash posted an update 7 months, 2 weeks ago

    In many cancers, incidence, treatment efficacy and overall prognosis vary between geographic populations. Studies disentangling the contributing factors may help in both understanding cancer biology and tailoring therapeutic interventions. Ancestry estimation in such studies should preferably be driven by genomic data, due to frequently missing or…[Read more]

  • Nash posted an update 7 months, 2 weeks ago

    Antiviral treatments targeting the coronavirus disease 2019 are urgently required. We screened a panel of already approved drugs in a cell culture model of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and identified two new agents having higher antiviral potentials than the drug candidates such as remdesivir and chroloquine in…[Read more]

  • Nash posted an update 7 months, 2 weeks ago

    Importantly, the acquisition of stem cell properties favors the resistance to standard care chemotherapies. Hence, a better understanding of this process could pave the way for the development of therapies targeting CSC metabolism, providing new strategies to eradicate the whole tumor mass in cancers with unmet needs.A highly sustainable method…[Read more]

  • Nash posted an update 7 months, 2 weeks ago

    g., optic neuritis, white matter changes), or standard rat brain immunohistochemistry (e.g., AQP4 reactivity). GFAP-Ab did not associate with distinct clinical-radiologic features. NS-Ab were suggested by MRI findings (e.g., medial temporal lobe changes [AMPAR-Ab], or multifocal cortico-subcortical abnormalities [GABAaR-Ab]), uncommon comorbid…[Read more]

  • Nash became a registered member 7 months, 2 weeks ago

Skip to toolbar